Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

RxSight, Inc. - Common Stock (NQ:RXST)

16.62 +0.30 (+1.84%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about RxSight, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
RxSight, Inc. to Participate in the Stifel 2025 Virtual Ophthalmology Forum
From RxSight, Inc.
Via GlobeNewswire
Gapping stocks in Monday's session
Let's have a look at what is happening on the US markets on Monday. Below you can find the gap up and gap down stocks in today's session. 
Via Chartmill
Deep Dive Into RxSight Stock: Analyst Perspectives (13 Ratings)
Via Benzinga
Top 3 Health Care Stocks That Are Preparing To Pump This Quarter
Via Benzinga
Earnings Scheduled For May 7, 2025
Via Benzinga
Expert Outlook: RxSight Through The Eyes Of 11 Analysts
Via Benzinga
Earnings Scheduled For February 25, 2025
Via Benzinga
RxSight, Inc. Reports First Quarter 2025 Financial Results
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. to Present at the Bank of America Healthcare Conference
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. to Report First Quarter 2025 Financial Results on May 7, 2025
From RxSight, Inc.
Via GlobeNewswire
This Aurora Innovation Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday
Via Benzinga
Deep Dive Into RxSight Stock: Analyst Perspectives (12 Ratings)
Via Benzinga
What's going on in today's session
Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements. 
Via Chartmill
RxSight Analyst Flags Growth Slowdown As Revised Outlook Misses Expectations
RxSight revised its FY25 revenue outlook below estimates, with Q1 sales lagging expectations. BofA downgraded the stock, citing slowing growth and risks ahead. 
Via Benzinga
Let's have a look at the top gainers and losers in the middle of the day of today's session.
Looking for insights into the US markets in the middle of the day on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
11 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
The market is filled with gapping stocks in Thursday's session.
The market is buzzing with gapping stocks on Thursday. Let's uncover which stocks are experiencing notable gaps during today's session. 
Via Chartmill
These stocks that are showing activity before the opening bell on Thursday.
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. 
Via Chartmill
Dow Tumbles Over 1,100 Points; US Initial Jobless Claims Fall
Via Benzinga
Topics Stocks
Exposures US Equities
RH Posts Downbeat Earnings, Joins Apple, Tesla, Nvidia And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
RxSight Warns On FY25 Revenue As Premium Cataract Market Faces Headwinds, Stock Plunges
RxSight shares down premarket on revised FY25 outlook. CEO cites headwinds in premium IOL market and economy. 
Via Benzinga
Why Penguin Solutions Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Via Benzinga
RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference
From RxSight, Inc.
Via GlobeNewswire
The Analyst Verdict: RxSight In The Eyes Of 9 Experts
Via Benzinga
RxSight, Inc. Reports Fourth Quarter and Full-Year 2024 Financial Results, Reaffirms 2025 Guidance
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. to Report Fourth Quarter Financial Results on February 25, 2025
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference
From RxSight, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.